HomePress-release

Redding, California - January 27, 2025

Attention Deficit Hyperactivity Disorder (ADHD) Market to Reach $23.66 Billion by 2031

Attention Deficit Hyperactivity Disorder (ADHD) Market Size, Share, Forecast, & Trends Analysis by Drug Type (Stimulants, Non-Stimulants), Age Group (Pediatric-Adolescents, Adults), Distribution Channel (Retail, Hospital, Online Pharmacies) - Global Forecast to 2031

Meticulous Research^®— a leading global market research company, published a research report titled ‘Attention Deficit Hyperactivity Disorder (ADHD) Market—Global Opportunity Analysis and Industry Forecast (2025 -2031)’. According to this latest publication, the attention deficit hyperactivity disorder market is expected to reach $23.66 billion by 2031, at a CAGR of 6% from 2024 to 2031.

The increasing incidence and awareness of ADHD across age groups is driving the growth of the attention deficit hyperactivity disorder market. Additionally, rising advancements in treatment options and growing non-pharmacological treatments create significant opportunities for market players. Furthermore, the rising focus on personalized treatment and growth of digital therapeutics are major trends in the market.

Key Players:

The attention deficit hyperactivity disorder market is characterized by a moderately competitive scenario due to the presence of many large- and small-sized global, regional, and local players. The key players operating in the global attention deficit hyperactivity disorder market are Eli Lilly and Company (U.S.), Lupin Limited (India), Mallinckrodt plc (Ireland), Tris Pharma, Inc (U.S.), Takeda Pharmaceutical Company Limited (Japan), Zevra Therapeutics, Inc. (U.S.), Novartis AG (Switzerland), Aytu Biopharma, Inc. (U.S.), Otsuka Pharmaceutical Co., Ltd. (Japan), Johnson & Johnson (U.S.), Alora Pharmaceuticals, LLC (U.S.), Supernus Pharmaceuticals, Inc. (U.S.), and Noven Pharmaceuticals, Inc. (U.S.) among others.

The attention deficit hyperactivity disorder market is segmented based on drug type, age group, and distribution channel. The report also evaluates industry competitors and analyzes the market at the regional and country levels.

Among all the drug types studied in this report, in 2024, the stimulant segment is expected to dominate the attention deficit hyperactivity disorder market. The rapid onset of effects, endorsement by medical guidelines, efficacy of stimulant medications, and rising product innovations and approvals contribute to the segment’s dominant position in the attention deficit hyperactivity disorder market. Stimulants help improve focus, reduce impulsivity, and manage hyperactive behaviors. Additionally, stimulants increase the levels of dopamine and norepinephrine in the brain, which are crucial for motivation, pleasure, and attention. Norepinephrine plays a vital role in enhancing alertness and focus, further boosting the popularity of stimulants and fueling market growth.

Among all the age groups studied in this report, the pediatric-adolescent age group segment is anticipated to hold the dominant position, with a large share of the attention deficit hyperactivity disorder market in 2025. The growing focus on pediatric health and nutrition and the early onset of ADHD among children and adolescents, along with growing awareness among parents, supports the segment's dominance in the attention deficit hyperactivity disorder market. According to the Centers for Disease Control and Prevention (CDC), in 2022, approximately 7 million children aged 3–17 in the U.S. have ever been diagnosed with ADHD compared to 2016. ADHD diagnosis in children varies from 6% to 16%.

Among all the distribution channels studied in this report, the retail pharmacies segment is expected to dominate the attention deficit hyperactivity disorder market in 2025. The convenience of in-person shopping, coupled with trusted pharmacist guidance, ease of access, and increasing volume of prescriptions for ADHD drugs, contribute to the segment’s dominant position in the attention deficit hyperactivity disorder market. Additionally, the growing trend of self-medication and increasing consumer confidence in over-the-counter ADHD drugs further fuel market growth.

Geographic Review

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, U.K., Spain, Italy, France, and Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, and Rest of Latin America), and the Middle East & Africa (Saudi Arabia, UAE, and Rest of Middle East & Africa)

Among the geographies studied in this report, in 2025, North America is expected to dominate the global attention deficit hyperactivity disorder market. The substantial share of this regional market can be attributed to several factors, including the rising prescription medications, growing focus on mental health and wellbeing, increasing product innovations, and the increasing prevalence of ADHD among children and adults in the U.S. Furthermore, in 2024, the U.S. is expected to account for a larger share of the ADHD market in North America.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=6132

Key Questions Answered in the Report-

What is the value of revenue generated by the sale of attention deficit hyperactivity disorder?
At what rate is the global demand for attention deficit hyperactivity disorder projected to grow for the next five to seven years?
What is the historical market size and growth rate for the attention deficit hyperactivity disorder market?
What are the major factors impacting the growth of this market at the global and regional levels?
What are the major opportunities for existing players and new entrants in the market?
Which drug type, age group, and distribution channel segments create major traction for the manufacturers in this market?
What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for manufacturers in the attention deficit hyperactivity disorder market?
Who are the major players in the attention deficit hyperactivity disorder market? What are their specific product offerings in this market?
What recent developments have taken place in the attention deficit hyperactivity disorder market? What impact have these strategic developments created on the market?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

3D Printing

5G Technology

Advanced Chemical & Materials

Agrochemicals

Algae Products

Alternative Proteins

Animal Health

Artificial Intelligence

Automotive Technologies

Big Data Analytics

Climate Technologies

Edible Insects

Electric Vehicle

Food & Agriculture Technologies

Hydrogen Technologies

Internet Of Things

In Vitro Diagnostics

Laboratory Instrumentation

Language Learning Technologies

Medical Technologies

Next Generation Technologies

Processing & Packaging Technologies

Robotics & Automation

Smart Technologies

Water & WastewaterTechnologies

Miscellaneous / Others

Redding, California - January 27, 2025

Attention Deficit Hyperactivity Disorder (ADHD) Market to Reach $23.66 Billion by 2031

Attention Deficit Hyperactivity Disorder (ADHD) Market Size, Share, Forecast, & Trends Analysis by Drug Type (Stimulants, Non-Stimulants), Age Group (Pediatric-Adolescents, Adults), Distribution Channel (Retail, Hospital, Online Pharmacies) - Global Forecast to 2031

Recommended Readings

Advanced Chemical &
Materials

Food & Agriculture
Technologies

Next Generation
Technologies

Processing & Packaging
Technologies

Water & Wastewater
Technologies